SEC paused Nasdaq's bitcoin options plan. CME says the wrong regulator approved it.
QBTC is now less about bitcoin demand and more about who gets to police the trade.
CryptoVibe Desk · bitcoin · sec · cme
- →The SEC paused Nasdaq PHLX's QBTC approval while it reviews CME's June 11 challenge.
- →CME says the product tracks bitcoin directly, so the CFTC should handle it instead of the SEC.
- →Watch the Aug. 24 comment deadline for whether other exchanges back CME or defend Nasdaq's route.
- cash-settled options → Contracts that pay winners in dollars instead of delivering the asset itself.
- CFTC → The U.S. agency that oversees commodities markets, including regulated bitcoin futures.
- CFTC exemptive relief → A formal CFTC signoff that lets a product launch despite a rule or jurisdiction question.
On Aug. 1, the SEC paused Nasdaq PHLX's QBTC approval.
The SEC approved the Nasdaq Bitcoin Index Options plan on May 22, per its exchange file. CME challenged that approval on June 11. CoinDesk reports comments are due Aug. 24.
The fight is simple. CME says QBTC is a commodity option tied directly to bitcoin. That means the CFTC should have the lead, not the SEC.
Nasdaq PHLX wanted to list cash-settled options under ticker QBTC. The product would pay in dollars, not bitcoin. But the index still tracks bitcoin, and that's the catch.
The May order already had a second gate. Nasdaq still needed CFTC exemptive relief before launch. CME is now saying that gate is not paperwork. It is the main question.
If you trade bitcoin options, this is not just agency drama. CME says Nasdaq's product would compete with regulated bitcoin futures and options markets. It says Nasdaq would skip the CFTC framework CME has to use.
The tape matches the story. This is a market-structure fight before it is a bitcoin story. The number to watch is Aug. 24, because the comment file will show who wants QBTC delayed and who wants the SEC route to stand.
The SEC's pause is the right call because CME's petition names the jurisdiction gap Nasdaq tried to route around.
By Aug. 24, watch whether at least one major exchange files a comment backing CME's CFTC argument or Nasdaq PHLX stands alone.
Primary links and supporting reads used by the desk for this story.
Forward this.
